Effect of human epidermal growth factor receptor 2 signalling on the IFN-γ pathway in luminal B breast cancer

Wiede, Louisa L. (2024) Effect of human epidermal growth factor receptor 2 signalling on the IFN-γ pathway in luminal B breast cancer. Masters thesis, Memorial University of Newfoundland.

[English] PDF - Accepted Version Available under License - The author retains copyright ownership and moral rights in this thesis. Neither the thesis nor substantial extracts from it may be printed or otherwise reproduced without the author's permission. Download (140MB)

Abstract

Previous studies showed luminal B (Human epidermal growth factor 2 +(HER2+) Estrogen receptor + (ER+) human breast carcinomas, compared to other breast cancer subtypes, are deficient in human leukocyte antigen (HLA) expression. Similarly, representative breast cancer cell line BT-474 (HER2+ER+) exhibited significantly reduced IFN-γ-inducible HLA expression, as compared to MCF-7 (HER2-ER+) and SKBR3 (HER2+ER-). Therefore, we hypothesized hyperactivation of HER2 signalling in ER+ breast cancer may interfere with interferon gamma (IFN-γ) pathway activation. To test this hypothesis, time course studies, targeted inhibition of HER2 (lapatinib or trastuzumab+pertuzumab) and ER (tamoxifen and ICI) and small interfering RNAs (siRNAs) targeting HER2 (ERBB2) and/or ER (ESR1) pathways were performed. Changes in IFN-γ pathway components, HER2, ER and HLA Class I in BT-474 and SKBR3, were assessed by flow cytometry and western blotting. Kinetic studies showed no clear inverse correlation between HER2 levels and surface HLA Class I while HER2 inhibition or knockdown resulted in reduced surface interferon gamma receptor 1 (IFNGR1) and HLA Class I. Neither phosphorylated signal transducer and activator of transcription (pSTAT- 1) nor interferon regulatory factor 1 (IRF-1) were significantly altered in BT-474 or SKBR3. The results suggest expression levels and/or function of IFN-γ pathway proteins may be dysregulated, likely independent of HER2 overexpression, resulting in weak IFN-γ signalling in BT-474 (HER2+ER+) and subsequent poor HLA Class I upregulation.

Actions (login required)

View Item